Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer Cells<i>via</i>Strong P-gp Inhibition
JAE HYEON PARK(Sungkyunkwan University), Sungpil Yoon(Sungkyunkwan University)
Cited by 5
Related Papers
Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
|British Journal of Pharmacology|2010|133
Attenuation of Colchicine Toxicity in Drug-resistant Cancer Cells by Co-treatment with Anti-malarial Drugs
|Anticancer Research|2016|36
Highly Halaven-resistant KBV20C Cancer Cells Can Be Sensitized by Co-treatment with Fluphenazine
|Anticancer Research|2016|27